News & Updates

Maternal influenza vaccination appears to confer benefits to infants, having been associated with a reduced risk of infant influenza hospitalizations within a tropical setting, as shown in a retrospective study from Singapore.

Therapeutic drug monitoring (TDM) of antimicrobial agents in a paediatric setting succeeds in recognizing out-of-range serum drug concentrations (SDC), specifically for vancomycin and aminoglycosides, according to a single-centre study.

Twice-yearly subcutaneous lenacapavir continues to show high efficacy and is well tolerated among cisgender men and gender-diverse individuals in the open-label extension (OLE) of the PURPOSE 2 trial.

Among treatment-naïve adults with HIV who are initiating antiretroviral therapy (ART), a regimen containing doravirine, lamivudine, and tenofovir disoproxil fumarate (DOR/3TC/TDF) is as good as the dolutegravir, emtricitabine, and tenofovir alafenamide (DTG/FTC/TAF) regimen in terms of viral suppression but is associated with less weight gain, according to the open-label, head-to-head OPTI-DOR study conducted in South Africa.

Discontinuing tenofovir in antiretroviral therapy (ART) may expose people living with HIV to hepatitis B virus (HBV)-related risks, including reactivation in those previously exposed and infection in those who are susceptible, according to a systematic review and meta-analysis.

Vaccination against COVID-19 lowers the risk of developing long COVID symptoms, and this protective effect persists for up to 7 months following vaccination, as shown in a retrospective study.